ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 614495 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 614495; 2) Community: the network communities that were significantly associated with the response to NSC 614495; 3) Molecule: the relationships between components within communities and NSC 614495; 4) MDR: the compounds that were significantly associated with the NSC 614495.

NSC Compound Enrichment Correlation
NSC 726144 Waol A FD-211 0.000880521445136051 0.0089374872
NSC 328410 Camptothecin Derivative 0.000931492155975116 0.42444151
NSC 287459 Cytarabine AY 0.00109467026514912 0.37291794
NSC 693167 Null 0.00109467026514912 0.26152489
NSC 105509 Null 0.00119931827492064 -0.13084096
NSC 50567 Null 0.00138752552318951 0.080030141
NSC 663790 Null 0.00138752552318951 0.18711778
NSC 728979 6-(3-Azidopropyl)-5,6-dihydro-8,9-methylenedioxy-3-nitro-5,1 1-dioxo-11H-indeno[1,2-c]isoquinoline 0.00138752552318951 0.31730325
NSC 176323 Camptothecin Derivative 0.0018088833864761 0.36661961
NSC 292816 1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) 0.0018088833864761 0.2293886
Total:53  Current:2    [First] [Prev] [Next] [Last]